Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus.

The most common diseases that require salvage therapy are HIV and various tumors.

They are also useful in salvage therapy for patients whose virus has mutated and acquired resistance to other drugs.

Posaconazole has been approved by the European Commission as salvage therapy for refractory coccidioidomycosis.

Voriconazole is also being studied in salvage therapy for refractory cases.

Predictors of initial treatment failure and results of salvage therapy.

Capecitabine, a prodrug converted into 5-FU within tumor cells, has been used as salvage therapy with some considerable success.

Efforts to find effective drug combinations for people with highly resistant viruses are called salvage therapy.

The necessity of second-line salvage therapy for those who relapse is accepted in these trials.

It is not considered a first-line treatment, but it can be useful as salvage therapy.